Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Early Bactericidal Activity of Cephalexin and Amoxicillin-clavulanate for Susceptible Tuberculosis - BLAST 1 Trial

NCT05664568 is registered in ClinicalTrials.gov with Western Sydney Local Health District as lead sponsor.

NCT NCT05664568
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05664568 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Early Bactericidal Activity of Cephalexin and Amoxicillin-clavulanate for Susceptible Tuberculosis - BLAST 1 Trial
Lead sponsor
Western Sydney Local Health District
Phase
Phase 2
Overall status
Unknown status
Start date
March 15, 2023
Completion date
December 31, 2024
Enrollment
30 (estimated)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

tuberculosis, pulmonary